KYRNF vs PFE: Which Stock is Better?

Side-by-side comparison of KYORIN Pharmaceutical Co., Ltd. and Pfizer Inc in 2026

Comparison Updated:

KYRNF

KYORIN Pharmaceutical Co., Ltd.

$10.31

PFE

Pfizer Inc

$27.56

Key Metrics Comparison

MetricKYRNFPFEWinner
Market Cap$592.33M$154.84BPFE
P/E Ratio10.1120.01KYRNF
EPS (TTM)$1.02$1.36PFE
Revenue Growth-0.0%-0.0%Tie
Gross Margin45.3%75.8%PFE

Analyze KYRNF

Full quant analysis

Analyze PFE

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is KYRNF or PFE a better investment?

Comparing KYRNF and PFE: KYORIN Pharmaceutical Co., Ltd. has a market cap of $592.33M while Pfizer Inc has $154.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between KYRNF and PFE?

KYRNF (KYORIN Pharmaceutical Co., Ltd.) and PFE (Pfizer Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: KYRNF or PFE?

Based on P/E ratios, KYRNF trades at a lower multiple (10.1x vs 20.0x).

Which is growing faster: KYRNF or PFE?

Both KYRNF and PFE show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: KYRNF or PFE?

Pfizer Inc (PFE) has higher gross margins at 75.8% compared to 45.3% for KYRNF.

Which is the larger company: KYRNF or PFE?

Pfizer Inc (PFE) is larger with a market cap of $154.84B compared to $592.33M for KYRNF.

Should I buy KYRNF or PFE in 2026?

Both KYRNF and PFE have investment merit. KYRNF trades at $10.31 while PFE trades at $27.56. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between KYRNF and PFE stock?

Key differences: Market Cap ($592.33M vs $154.84B), P/E Ratio (10.1x vs 20.0x), Revenue Growth (-0.0% vs -0.0%), Gross Margin (45.3% vs 75.8%).

Popular Stock Comparisons